News & Analysis on Clinical Trial Services & Contract Research And Development
Fusion Antibodies revenue grew 41% in FY2018, and while “pop up consultants” have created new competition, the CRO is differentiating itself by investing in its services and focusing on quality.
The multi-phase collaboration between WuXi AppTec Research Service Division and Cyclica looks to advance polypharmacology in drug discovery using AI-augmented technology.
Cancer Prevention Pharmaceuticals has signed a licensing agreement with Mallinckrodt Pharma for commercialization rights to its lead drug candidate.
The Coalition for Epidemic Preparedness Innovations announced a collaboration with IDT Biologika for MERS vaccine development in which IDT will receive up to $36m.